A detailed history of Petredis Investment Advisors LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Petredis Investment Advisors LLC holds 39,850 shares of MRK stock, worth $3.98 Million. This represents 0.48% of its overall portfolio holdings.

Number of Shares
39,850
Previous 39,679 0.43%
Holding current value
$3.98 Million
Previous $4.91 Billion 7.88%
% of portfolio
0.48%
Previous 0.55%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$111.15 - $128.97 $19,006 - $22,053
171 Added 0.43%
39,850 $4.53 Billion
Q2 2024

Jul 16, 2024

SELL
$123.8 - $132.96 $3,714 - $3,988
-30 Reduced 0.08%
39,679 $4.91 Billion
Q1 2024

Apr 25, 2024

BUY
$113.24 - $131.95 $90,025 - $104,900
795 Added 2.04%
39,709 $5.24 Billion
Q4 2023

May 20, 2024

SELL
$100.18 - $109.02 $119,214 - $129,733
-1,190 Reduced 2.99%
38,594 $4.21 Billion
Q4 2023

Feb 14, 2024

SELL
$100.18 - $109.02 $87,156 - $94,847
-870 Reduced 2.19%
38,914 $4.24 Billion
Q3 2023

May 20, 2024

BUY
$102.95 - $114.33 $15,236 - $16,920
148 Added 0.37%
39,784 $4.1 Billion
Q3 2023

Nov 01, 2023

BUY
$102.95 - $114.33 $15,236 - $16,920
148 Added 0.37%
39,784 $4.1 Billion
Q2 2023

May 20, 2024

BUY
$108.61 - $118.38 $2,172 - $2,367
20 Added 0.05%
39,636 $4.57 Billion
Q2 2023

Aug 07, 2023

BUY
$108.61 - $118.38 $2,172 - $2,367
20 Added 0.05%
39,636 $4.57 Billion
Q1 2023

May 20, 2024

BUY
$102.94 - $114.86 $59,190 - $66,044
575 Added 1.47%
39,616 $4.21 Billion
Q1 2023

May 03, 2023

BUY
$102.94 - $114.86 $59,190 - $66,044
575 Added 1.47%
39,616 $4.21 Billion
Q4 2022

May 20, 2024

SELL
$87.44 - $112.11 $58,409 - $74,889
-668 Reduced 1.68%
39,041 $4.33 Billion
Q4 2022

Feb 06, 2023

BUY
$87.44 - $112.11 $3.41 Million - $4.38 Million
39,041 New
39,041 $4.33 Billion

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $253B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Petredis Investment Advisors LLC Portfolio

Follow Petredis Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Petredis Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Petredis Investment Advisors LLC with notifications on news.